Product Information
TERIFLUNOMIDE 14 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.3692 per EA under NDC 62332031430. Its NADAC has been published 145 times since Sep 20, 2023.
Strength
14 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332031430
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TERIFLUNOMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209572On Market Since
1/25/2023
Pharmacological Classes
Price Statistics
The NADAC for TERIFLUNOMIDE 14 MG TABLET has been published 145 times since Sep 20, 2023, and over the history we have for it it has declined 59.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3692 per EA |
|---|---|
| All-time high | $0.9109 (Oct 11, 2023) |
| All-time low | $0.3426 (Jul 17, 2024) |
| 52-week high | $0.7383 |
| 52-week low | $0.3692 |
| Median price | $0.6964 |
| Average price | $0.6863 |
| Largest weekly change | +63.1% (Aug 21, 2024) |
| Weeks tracked | 145 |
| Tracking since | Sep 20, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the TERIFLUNOMIDE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of TERIFLUNOMIDE 14 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TERIFLUNOMIDE 14 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.3692 per EA (NDC 62332031430), effective Jun 24, 2026.
How has the price of TERIFLUNOMIDE 14 MG TABLET changed over time?
Over the history we have for it, the NADAC for TERIFLUNOMIDE 14 MG TABLET has declined 59.5%. It has been tracked across 145 weekly CMS publications since Sep 20, 2023.
What are the highest and lowest recorded NADAC prices for TERIFLUNOMIDE 14 MG TABLET?
Since Sep 20, 2023, the NADAC for TERIFLUNOMIDE 14 MG TABLET has ranged from a low of $0.3426 (Jul 17, 2024) to a high of $0.9109 (Oct 11, 2023), with a median of $0.6964 per EA.
Are there cheaper alternatives to TERIFLUNOMIDE 14 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of TERIFLUNOMIDE 14 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures TERIFLUNOMIDE 14 MG TABLET?
TERIFLUNOMIDE 14 MG TABLET (NDC 62332031430) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification